Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]ABY-025 PET Imaging for HER2 Expression in Metastatic Breast Cancer
NCT01858116Phase 2Completed
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-ABY-025 in breast cancer. Started Apr 2013; status: completed.
02
Drugs
68Ga-ABY-025
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01858116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858116.